Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-07-31 Sale |
2023-08-02 4:21 pm |
Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer |
7,348 | $3.95 | $29,025 | 0 (Direct) |
View |
| 2023-07-17 Sale |
2023-07-18 8:27 pm |
Syros Pharmaceuticals Inc. | SYRS | Olson Eric R Chief Scientific Officer |
689 | $3.5 | $2,412 | 6,661 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-10-31 Exercise |
2023-11-02 4:54 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Simonian Nancy A President & CEO |
40,125 | $0 | 140,269 (Direct) |
View |
| 2023-11-01 Tax Withholding |
2023-11-02 4:54 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Simonian Nancy A President & CEO |
13,401 | $2.22 | 140,269 (Direct) |
View |
| 2023-10-31 Exercise |
2023-11-02 4:53 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Haas Jason Chief Financial Officer |
18,875 | $0 | 32,826 (Direct) |
View |
| 2023-11-01 Tax Withholding |
2023-11-02 4:53 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Haas Jason Chief Financial Officer |
6,301 | $2.22 | 32,826 (Direct) |
View |
| 2023-10-31 Exercise |
2023-11-02 4:52 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer |
18,875 | $0 | 31,449 (Direct) |
View |
| 2023-11-01 Tax Withholding |
2023-11-02 4:52 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer |
6,301 | $2.22 | 31,449 (Direct) |
View |
| 2023-10-31 Exercise |
2023-11-02 4:52 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Stephens Kristin Chief Development Officer |
17,000 | $0 | 32,789 (Direct) |
View |
| 2023-11-01 Tax Withholding |
2023-11-02 4:52 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Stephens Kristin Chief Development Officer |
5,676 | $2.22 | 32,789 (Direct) |
View |
| 2023-10-31 Exercise |
2023-11-02 4:51 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Chee Conley Chief Commercial Officer |
17,000 | $0 | 29,338 (Direct) |
View |
| 2023-11-01 Tax Withholding |
2023-11-02 4:51 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Chee Conley Chief Commercial Officer |
6,004 | $2.22 | 29,338 (Direct) |
View |
| 2023-10-11 Exercise |
2023-10-20 4:23 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Quirk Gerald E Chief Legal & Compliance Offic |
22,500 | $0 | 46,803 (Direct) |
View |
| 2023-10-19 Tax Withholding |
2023-10-20 4:23 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Quirk Gerald E Chief Legal & Compliance Offic |
6,897 | $2.1 | 46,803 (Direct) |
View |
| 2023-09-16 Exercise |
2023-09-19 4:48 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Young Richard A Director |
2,666 | $0 | 44,171 (Direct) |
View |
| 2023-09-16 Exercise |
2023-09-19 4:47 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Alles Mark J Director |
2,666 | $0 | 9,000 (Direct) |
View |
| 2023-09-16 Exercise |
2023-09-19 4:46 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | AKKARAJU SRINIVAS Director |
2,666 | $0 | 8,000 (Direct) |
View |
| 2023-09-12 Option Award |
2023-09-14 4:05 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Quirk Gerald E Chief Legal & Compliance Offic |
30,000 | $0 | 30,000 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-02 4:27 pm |
N/A 2033-05-31 |
Syros Pharmaceuticals Inc. | SYRS | Young Richard A Director |
10,000 | $0 | 42,171 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-02 4:26 pm |
N/A 2033-05-31 |
Syros Pharmaceuticals Inc. | SYRS | WIRTH PETER Director |
10,000 | $0 | 18,000 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-02 4:26 pm |
N/A 2033-05-31 |
Syros Pharmaceuticals Inc. | SYRS | TYSON TIMOTHY Director |
10,000 | $0 | 35,189 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-02 4:25 pm |
N/A 2033-05-31 |
Syros Pharmaceuticals Inc. | SYRS | OH ANDREW M. Director |
10,000 | $0 | 18,000 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-02 4:24 pm |
N/A 2033-05-31 |
Syros Pharmaceuticals Inc. | SYRS | Fanucci Marsha Director |
10,000 | $0 | 18,000 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-02 4:24 pm |
N/A 2033-05-31 |
Syros Pharmaceuticals Inc. | SYRS | Eckhardt Sue Gail Director |
10,000 | $0 | 18,000 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-02 4:23 pm |
N/A 2033-05-31 |
Syros Pharmaceuticals Inc. | SYRS | Dunsire Deborah Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-02 4:22 pm |
N/A 2033-05-31 |
Syros Pharmaceuticals Inc. | SYRS | Alles Mark J Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-02 4:22 pm |
N/A 2033-05-31 |
Syros Pharmaceuticals Inc. | SYRS | AKKARAJU SRINIVAS Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2022-09-16 Option Award(A) |
2023-04-20 4:41 pm |
N/A 2032-09-15 |
Syros Pharmaceuticals Inc. | SYRS | TYSON TIMOTHY Director |
41,811 | $0 | 41,811 (Direct) |
View |
| 2022-09-16 Option Award(A) |
2023-04-20 4:39 pm |
N/A 2032-09-15 |
Syros Pharmaceuticals Inc. | SYRS | AKKARAJU SRINIVAS Director |
711,489 | $0 | 1,592,939 (Direct) |
View |
| 2023-03-31 Exercise |
2023-04-04 6:57 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Haas Jason Chief Financial Officer |
2,000 | $0 | 7,377 (Direct) |
View |
| 2023-04-03 Tax Withholding |
2023-04-04 6:57 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Haas Jason Chief Financial Officer |
623 | $2.58 | 7,377 (Direct) |
View |
| 2023-03-31 Exercise |
2023-04-04 6:56 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Chee Conley Chief Commercial Officer |
2,000 | $0 | 7,342 (Direct) |
View |
| 2023-04-03 Tax Withholding |
2023-04-04 6:56 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Chee Conley Chief Commercial Officer |
658 | $2.58 | 7,342 (Direct) |
View |
| 2023-03-31 Exercise |
2023-04-04 6:56 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer |
2,000 | $0 | 13,348 (Direct) |
View |
| 2023-04-03 Tax Withholding |
2023-04-04 6:56 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer |
623 | $2.58 | 13,348 (Direct) |
View |
| 2023-03-31 Exercise |
2023-04-04 6:55 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Stephens Kristin Chief Development Officer |
2,000 | $0 | 10,465 (Direct) |
View |
| 2023-04-03 Tax Withholding |
2023-04-04 6:55 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Stephens Kristin Chief Development Officer |
623 | $2.58 | 10,465 (Direct) |
View |
| 2023-03-31 Exercise |
2023-04-04 6:54 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Olson Eric R Chief Scientific Officer |
2,000 | $0 | 13,350 (Direct) |
View |
| 2023-04-03 Tax Withholding |
2023-04-04 6:54 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Olson Eric R Chief Scientific Officer |
623 | $2.58 | 13,350 (Direct) |
View |
| 2023-03-31 Exercise |
2023-04-04 6:54 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Simonian Nancy A President & CEO |
6,000 | $0 | 91,420 (Direct) |
View |
| 2023-04-03 Tax Withholding |
2023-04-04 6:54 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Simonian Nancy A President & CEO |
1,852 | $2.58 | 91,420 (Direct) |
View |
| 2023-02-16 Option Award |
2023-02-21 4:27 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Stephens Kristin Chief Development Officer |
35,000 | $0 | 35,000 (Direct) |
View |
| 2023-02-16 Option Award |
2023-02-21 4:24 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer |
40,000 | $0 | 40,000 (Direct) |
View |
| 2023-02-16 Option Award |
2023-02-21 4:23 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Olson Eric R Chief Scientific Officer |
35,000 | $0 | 35,000 (Direct) |
View |
| 2023-02-16 Option Award |
2023-02-21 4:21 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Haas Jason Chief Financial Officer |
40,000 | $0 | 40,000 (Direct) |
View |
| 2023-02-16 Option Award |
2023-02-21 4:19 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Chee Conley Chief Commercial Officer |
35,000 | $0 | 35,000 (Direct) |
View |
| 2023-02-16 Option Award |
2023-02-21 4:17 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Simonian Nancy A President & CEO |
118,700 | $0 | 118,700 (Direct) |
View |
| 2022-10-11 Option Award |
2022-10-13 4:20 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Quirk Gerald E Chief Legal Officer |
45,000 | $0 | 45,000 (Direct) |
View |
Ownership |
2022-10-13 4:15 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Quirk Gerald E Chief Legal Officer |
0 | $0 | 50,702 (Direct) |
View |
| 2022-10-06 Option Award(A) |
2022-10-11 4:55 pm |
N/A 2032-10-05 |
Syros Pharmaceuticals Inc. | SYRS | Chee Conley Chief Commercial Officer |
78,500 | $0 | 78,500 (Direct) |
View |
| 2022-10-06 Option Award |
2022-10-11 4:40 pm |
N/A 2032-10-05 |
Syros Pharmaceuticals Inc. | SYRS | Chee Conley Chief Commercial Officer |
78,500 | $0 | 78,500 (Direct) |
View |